Verastem (VSTM) Change in Receivables (2018 - 2026)
Verastem's (VSTM) quarterly Change in Receivables came in at $1.3 million in Q1 2026, down 35.86% quarter-over-quarter from $2.1 million in Q4 2025.
Verastem (VSTM) Change in Receivables (2018 - 2026) Analysis & Trends
Verastem's Change in Receivables history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $8.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.8 million, changed N/A from the prior year.
- Change in Receivables eased to $1.3 million in Q1 2026 per VSTM's latest filing, from $2.1 million in the prior quarter.
- Across five years, Change in Receivables topped out at $4.6 million in Q3 2025 and bottomed at -$2.5 million in Q2 2022.
- The 4-year median for Change in Receivables is $0.0 (2023), against an average of $756600.0.
- Biggest YoY gain for Change in Receivables was 140.18% in 2022; the steepest drop was 287.21% in 2022.
- Year by year, Change in Receivables stood at -$43000.0 in 2022, then jumped by 95.35% to -$2000.0 in 2023, then soared by 104950.0% to $2.1 million in 2025, then tumbled by 35.86% to $1.3 million in 2026.
- Per Business Quant, the three latest VSTM Change in Receivables figures stand at $1.3 million (Q1 2026), $2.1 million (Q4 2025), and $4.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Verastem | 607.94 Mn | 410.11 Mn | 15.90 Mn | 1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Sep 30, 2023 | -2,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Dec 31, 2022 | -43,000.00 |
| Dec 31, 2022 | -43,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -2.51 Mn |
| Jun 30, 2022 | -2.51 Mn |
| Mar 31, 2022 | 2.13 Mn |
| Mar 31, 2022 | 2.13 Mn |